The Conference Programme
Thursday 13th March – Day 1
Early Career Research (ECR) pre-conference workshop
|
Welcome |
09.00 |
ECR Workshop open – poster set-up |
|
ECR Workshop |
10.00 |
ECR Workshop introduction & DPUK overview Prof Sarah Bauermeister (Oxford University) |
|
10.10 |
Opportunities available at ARUK Jacqui Hanley (Alzheimer’s Research UK) |
|
|
10.30 |
Opportunities for ECRs, including the importance of PPIEs Cherie Nyota (Alzheimer’s Society) |
|
|
10.50 |
Data Portal overview Emma Squires (Swansea University) |
|
|
11.00 |
Training and mentoring opportunities Prof Sarah Bauermeister (Oxford University) |
|
|
11.10 |
ECR presentation: Novel biomarker exploration within neuropathologies exhibiting netrin-1 pathway linked cognitive impairment Chelsea Povall (Alchemab) |
|
|
|
ECR presentation: The MIND diet and cognitive performance: a modulating role of CVD risk Megan Smith (University of Oxford) |
|
|
11.30 |
Career presentations:
|
|
|
11.45 |
Lessons learned from Lewy Prof John O'Brien (University of Cambridge) |
|
|
12.15 |
Q&A: Ask the panel |
|
|
|
12.30 |
Close |
Main conference Programme
|
|
11.30 |
Conference open – poster time |
|
|
12.00 |
Lunch - Refreshments, poster and stand time |
|
Introductory address |
1.00 |
Welcome |
|
Plenary |
|
Plenary presentation: Preparing for Next-Gen Therapies Professor John Gallacher, Director, Dementias Platform UK, University of Oxford |
|
Use of Biomarkers in Experimental Medicine
|
|
Theme overview by session chair (Prof James Rowe, Cambridge University) |
|
|
Keynote State of the Science of Plasma Biomarkers of Alzheimer’s Disease and Related Dementias |
|
|
|
PET/MRI Imaging in Dementia: Revolutionizing Clinical Trial Reliability and Efficiency Dr Pawel Markiewicz (University College London) |
|
|
3.10 |
Break – Refreshments and poster time |
|
|
|
The role of digital cognitive assessments in dementia drug development: responding to emerging challenges. Dr Francesca Cormack (Cambridge Cognition) |
|
|
|
Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders Dr Ivan Koychev (Imperial College, London) |
|
|
|
ECR flash talk: Drug repurposing for dementia in UK Biobank and SAIL cohorts Dr Jodi Watt (University of Glasgow) |
|
|
|
ECR flash talk: Gotcha! A trial of an app-based therapy for proper name anomia in people with dementia Dr Aygun Badalova (University College London) |
|
|
|
General discussion |
|
|
|
5.30 |
Drinks reception |
|
Close |
6.30 |
Guests depart |
Friday 14th March - Day 2
|
|
8.30 |
Conference open – Poster time |
|
|
9.00 |
Introduction A lived experience by Tim Little |
|
Data: From ‘omics to linkage
|
|
Theme overview by session chair (Prof Simon Thompson, Swansea University) |
|
|
Keynote A Global Approach to Informatics in ADRD |
|
|
|
Digital Technology in Parkinson's Disease Prof Michele Hu (University of Oxford) |
|
|
|
Role of AD Biomarkers in Dementia Research: an Epidemiological Perspective Dr Carole Dufouil (University of Bordeaux) |
|
|
11.00 |
Break – Refreshments, poster and stand time |
|
|
|
AI in Dementia Neuroimaging for Memory Clinics Dr Tim Rittman (University of Cambridge) |
|
|
|
ECR flash talk: AI-guided detection of Alzheimer’s disease based on blood markers and cognition outperforms biomarker-based diagnosis. Dr Chao Dong (University of Cambridge) |
|
|
|
ECR flash talk: Dynamics of cognitive variability with age and its genetic underpinning in NIHR BioResource Genes and Cognition cohort participants Dr Shafiqur Rahman (University of Cambridge) |
|
|
|
General discussion |
|
|
|
12.40 |
Lunch - Refreshments, poster and stand time |
|
|
1.35 |
Presentation of ECR Poster Prizes |
|
Trials delivery: Trials for all
|
|
Theme overview by session chair (Prof Vanessa Raymont, Oxford University) |
|
|
Keynote The Next Generation of CLinical Trials for Alzheimer's Disease |
|
|
|
Developing a Platform Trial in Symptomatic Alzheimer's Disease Prof Paresh Malhotra (Imperial College London) |
|
|
|
Equitable and Representative Trials Delivery in the UK Prof Charles Marshall (Queen Mary, University of London) |
|
|
3.30 |
Break – Refreshments, poster time |
|
|
|
Advancing Alzheimer's Disease Clinical Trials in the UK Dr Ruth Croney (Roche) Roche Products Limited has provided financial support for this meeting but has not been involved in the agenda other than this organised presentation |
|
|
|
ECR flash talk: Can sodium be used as a biomarker for vascular dementia? Evidence for widespread disturbed brain sodium homeostasis Dr Sasha Philbert (University of Manchester) |
|
|
|
ECR flash talk: Cross-sectional and longitudinal spectral differences in MEG brain networks differentiate Amyloid-positive Alzheimer’s patients Dr Mats van Es, University of Oxford |
|
|
|
General discussion |
|
|
Closing address |
5.10 |
The future landscape Prof John Gallacher (Oxford University), Director of Dementias Platform UK |
|
|
5.20 |
Close |